Several trials demonstrated that a long detection interval and a high-rate cutoff reduced
implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. However …

Background—Three trials demonstrated recently that a long detection window reduces
implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. Avoid …

Background A significant number of patients with an implantable cardioverter/defibrillator
(ICD) for primary prevention receive inappropriate shocks. Previous studies have reported a …

Background The implantable cardioverter–defibrillator (ICD) is highly effective in reducing
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …

Aims: We reviewed outcomes in our primary prevention implantable cardioverter defibrillator
(ICD) population according to whether the device was programmed with a single ventricular …

Introduction: Although numerous trials have shown benefit of implantable cardioverter
defibrillators (ICDs) for either primary or secondary prevention, no trial has prospectively …

Introduction: The purpose of this investigation is to evaluate whether a prolonged detection
interval for life threatening ventricular tachyarrhythmia (VT) is able to reduce therapies (Rx) …

Purpose Randomised trials have shown that empiric ICD programming, using long detection
times and high detection zones, reduces device therapy in ICD recipients. However, there is …

Background: Implantable cardioverter defibrillator (ICD) therapies, even when appropriate,
are associated with increased risk. Therapy-reducing strategies have been shown to reduce …

Background In Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate
Therapy (MADIT-RIT), high-rate cutoff (arm B) and delayed therapy (arm C) reduced the risk …